1. Home
  2. VFF vs AGEN Comparison

VFF vs AGEN Comparison

Compare VFF & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$2.91

Market Cap

230.2M

Sector

N/A

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$7.66

Market Cap

274.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFF
AGEN
Founded
1989
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.2M
274.8M
IPO Year
2013
1999

Fundamental Metrics

Financial Performance
Metric
VFF
AGEN
Price
$2.91
$7.66
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
1.2M
1.4M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
184.38
100.00
EPS
0.08
0.96
Revenue
$215,937,000.00
$42,877,086.00
Revenue This Year
$12.19
$107.63
Revenue Next Year
$15.82
N/A
P/E Ratio
$35.75
$8.14
Revenue Growth
N/A
89.95
52 Week Low
$1.81
$2.71
52 Week High
$4.99
$8.85

Technical Indicators

Market Signals
Indicator
VFF
AGEN
Relative Strength Index (RSI) 76.55 57.42
Support Level $2.75 $2.97
Resistance Level $2.94 $8.76
Average True Range (ATR) 0.13 0.58
MACD 0.04 -0.07
Stochastic Oscillator 86.82 60.69

Price Performance

Historical Comparison
VFF
AGEN

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: